About us

Eurofins CALIXAR is a cutting-edge biotechnology company at the forefront of innovative solutions in the field of protein research for drug discovery. Established in 2011, with a vision to revolutionize the way we understand and interact with proteins, Eurofins CALIXAR has become a prominent name in the life sciences industry. The company joined the Eurofins Discovery group in April 2023. With a team of dedicated and talented scientists, Eurofins CALIXAR specializes in the production, solubilization, stabilization, and characterization of challenging recombinant active proteins, which play a crucial role in various biological processes and are prime targets for drug development. Moreover, we offer you a wide range of ready-to-use proteins including kinases, phosphatases, membrane proteins, ubiquitins, or epigenetic proteins to assist you in your work in the research and development of new drugs. 

Trusted products to expedite your discovery & development – advance confidently

The company's unique technology and proprietary methodologies have enabled breakthroughs in membrane protein research, paving the way for the development of new therapeutics and vaccines. Eurofins CALIXAR is committed to scientific excellence and collaboration with pharmaceutical and biotech companies. 

The company's unique technology and proprietary methodologies have enabled breakthroughs in membrane protein research, paving the way for the development of new therapeutics and vaccines. Eurofins CALIXAR’s commitment to scientific excellence and collaboration with pharmaceutical and biotech companies has resulted in significant advancements in areas such as neurodegenerative diseases, infectious diseases, and cancer. Their work not only contributes to the advancement of scientific knowledge but also has the potential to improve the lives of millions through the discovery of new treatments and therapies.

Eurofins CALIXAR’s dedication to pushing the boundaries of science, coupled with their passion for addressing some of the most challenging problems in the field, sets them apart as a leader in membrane protein research. As they continue to make strides in drug discovery, Eurofins CALIXAR remains committed to their mission of enhancing our understanding of membrane proteins and accelerating the development of life-changing medicines.

Company

Eurofins CALIXAR's team, grounded in the corporate values of commitment, perseverance, and humanism, has propelled the company's growth since 2011. This expansion is attributed to various factors, including secured funding, the acquisition of new patents, the establishment of global offices, collaborative partnerships, presentations, and the publication of peer-reviewed articles.

Location

Eurofins CALIXAR, a biotechnology company specializing in active protein research, is headquartered in Lyon.

Career

Join the Eurofins CALIXAR’s team to overcome scientific challenges and discover our unique expertise.

News

Learn more about Eurofins CALIXAR through our news appearances, press releases and biotech events and find out why we are at the forefront of membrane protein technology.

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.